An increase in the concentrations of maternally circulating endoglin and sFlt1, and a subsequent decrease in placental growth factor (PlGF) signaling were identified as the major causal factors for the development of preeclampsia (1, 2). This evidence concerns the gene PGF and preeclampsia.